HEDIS® Results
Medicaid HEDIS® Annual Rates.
Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.
|
Measure |
2023 Rate |
2023 Goal |
2024 Rate |
2024 Goal |
|
Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA) |
62.54% |
64.90% |
64.79% |
66.15% |
|
Annual Dental Visits (ADV) Total |
48.70% |
54.60% |
|
|
|
Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment |
77.01% |
46.74% |
43.97% |
48.16% |
|
Appropriate Testing for Pharyngitis (CWP) |
76.25% |
77.56% |
85.28% |
85.11% |
|
Appropriate Treatment for Upper Respiratory Infection (URI) Total |
90.55% |
93.08% |
88.16% |
91.27% |
|
Asthma Medication Ratio (AMR) Total |
65.38% |
69.41% |
70.56% |
70.56% |
|
Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB) |
65.85% |
66.19% |
66.10% |
67.03% |
|
Blood Pressure Control (<140/90) for Patients With Diabetes (BPD) |
63.50% |
68.61% |
69.10% |
71.78% |
|
Breast Cancer Screening (BCS) |
48.27% |
55.25% |
|
|
|
Breast Cancer Screening (BCS-E) |
48.27% |
54.94% |
49.83% |
56.66% |
|
Cervical Cancer Screening (CCS) |
52.80% |
59.85% |
50.24% |
60.10% |
|
Childhood Immunization Status (CIS) Combination #10 |
21.17% |
35.04% |
20.68% |
31.32% |
|
Chlamydia Screening in Women (CHL) Total |
57.21% |
61.07% |
56.11% |
61.46% |
|
Controlling High Blood Pressure (CBP) |
60.34% |
65.45% |
64.81% |
67.40% |
|
Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD) |
82.30% |
80.86% |
82.84% |
83.51% |
|
Eye Exam for Patients With Diabetes (EED) |
45.50% |
56.20% |
45.26% |
57.09% |
|
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total |
28.52% |
27.73% |
25.78% |
27.62% |
|
Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total |
53.45% |
46.35% |
56.60% |
44.33% |
|
Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total |
29.80% |
41.03% |
32.71% |
42.86% |
|
Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total |
39.42% |
37.31% |
36.34% |
37.64% |
|
Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase |
44.38% |
57.90% |
50.24% |
56.86% |
|
Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase |
|
|
50.24% |
56.83% |
|
Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%) |
48.18% |
55.72% |
53.77% |
59.64% |
|
Immunizations for Adolescents (IMA) Combination #2 |
31.24% |
38.93% |
32.02% |
38.69% |
|
Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total |
12.22% |
16.94% |
11.94% |
16.78% |
|
Kidney Health Evaluation for Patients with Diabetes (KED) |
33.87% |
38.80% |
35.56% |
42.10% |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total |
30.34% |
39.01% |
31.49% |
41.92% |
|
Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total |
|
|
31.49% |
41.41% |
|
Pharmacotherapy for Opioid Use Disorder (POD) Total |
7.75% |
31.93% |
7.96% |
29.01% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids |
77.77% |
75.79% |
79.30% |
74.78% |
|
Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator |
87.45% |
86.96% |
85.85% |
86.54% |
|
Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years |
94.83% |
≤ 92.72% |
91.72% |
≤ 91.24% |
|
Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care |
84.67% |
86.86% |
90.16% |
86.89% |
|
Prenatal and Postpartum Care (PPC) Postpartum Care |
76.89% |
80.78% |
83.61% |
82.48% |
|
Prenatal Immunization Status (PRS) Combination Rate |
19.41% |
25.81% |
|
|
|
Prenatal Immunization Status (PRS-E) Combination Rate |
19.41% |
25.81% |
18.70% |
24.92% |
|
Risk of Continued Opioid Use (COU) 31-Day Total |
8.62% |
≤ 2.45% |
4.19% |
≤ 2.79% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total |
82.58% |
81.64% |
82.44% |
83.00% |
|
Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total |
92.26% |
73.63% |
72.93% |
74.07% |
|
Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy |
67.95% |
67.07% |
67.95% |
67.01% |
|
Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80% |
88.30% |
70.37% |
68.34% |
70.91% |
|
Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total |
54.32% |
63.89% |
54.92% |
64.10% |
|
Use of Imaging Studies for Low Back Pain (LBP) |
70.00% |
75.44% |
65.57% |
72.74% |
|
Use of Opioids at High Dosage (HDO) |
4.88% |
≤ 2.19% |
1.37% |
≤ 2.14% |
|
Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies |
1.10% |
≤ 0.87% |
1.99% |
≤ 1.22% |
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile |
78.10% |
83.21% |
76.46% |
86.20% |